2011 FDA drug approvals

被引：1

|

作者：

Asher Mullard

机构：

来源：

Nature Reviews Drug Discovery | 2012年 / 11卷 / 2期

关键词：

D O I：

10.1038/nrd3657

中图分类号：

学科分类号：

摘要：

The US FDA approved 30 new therapeutics last year, including 11 first-in-class agents.

引用

收藏

页码：91 / 94

页数：3

相关论文

共 50 条

[41] FDA approvals
不详
[J]. GERIATRICS, 2000, 55 (10) : 20 - 20
[42] FDA approvals
不详
[J]. AMERICAN FAMILY PHYSICIAN, 2003, 67 (12) : 2629 - 2629
[43] Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA
Lang Zheng
Wenjing Wang
Qiu Sun
[J]. Signal Transduction and Targeted Therapy, 9
[44] FDA may allow more conditional drug approvals
不详
[J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2014, 245 (09): : 992 - 992
[45] FDA enforcement efforts and drug approvals trend upward
Peters, Rita
[J]. BIOPHARM INTERNATIONAL, 2018, 31 (03) : 6 - 6
[46] Value of 2016 FDA drug approvals: reversion to the mean?
Schulze, Ulrik
Ringel, Michael
Panier, Valery
Baedeker, Mathias
[J]. NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (02) : 78 - 78
[47] FDA drug approvals: No worse is simply not good enough
不详
[J]. NATURE BIOTECHNOLOGY, 1996, 14 (04) : 403 - 403
[48] FDA approvals
不详
[J]. AMERICAN FAMILY PHYSICIAN, 2002, 66 (10) : 2007 - 2007
[49] FDA approvals
不详
[J]. GERIATRICS, 2000, 55 (07) : 24 - 24
[50] ON FDA APPROVALS
PICKNEY, ER
[J]. DISCOVER, 1983, 4 (05): : 101 - 101

← 1 2 3 4 5 →